BFM
PLRX icon

Boothbay Fund Management’s Pliant Therapeutics PLRX Stock Holding History

Boothbay Fund Management’s Portfolio PLRX Stock Details PLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$345K Buy
+303,000
New +$369K ﹤0.01% 1680
2021
Q3 		– Sell
-13,585
Closed -$396K – 2120
2021
Q2 		$396K Buy
13,585
+845
+7% +$26.3K 0.01% 1124
2021
Q1 		$501K Buy
+12,740
New +$414K 0.02% 946

Other funds holding PLRX

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $1.26B AUM 60.23% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return

Boothbay Fund Management's PLRX Position: Q2 2026 in Review

Boothbay Fund Management opened a new position in Pliant Therapeutics (PLRX) in Q2 2026: 303,000 shares worth $345K. The stake represents ﹤0.01% of the portfolio and ranks #1680 among its holdings. This is a return to the name: Boothbay Fund Management previously reported a position in PLRX as recently as Q2 2021.

Boothbay Fund Management first reported a position in PLRX in Q1 2021 and has held it in 3 quarters since. The position peaked at $501K in Q1 2021. 86 funds tracked by Wall St. Rank hold PLRX as of Q2 2026.

  • Boothbay Fund Management held 303,000 shares of Pliant Therapeutics worth $345K as of Q2 2026.
  • Pliant Therapeutics was a new Boothbay Fund Management position in Q2 2026.
  • Pliant Therapeutics made up ﹤0.01% of Boothbay Fund Management's portfolio in Q2 2026, its #1680 holding.
  • Boothbay Fund Management first reported a position in Pliant Therapeutics in Q1 2021 and has held it in 3 quarters since.
  • Boothbay Fund Management's Pliant Therapeutics position peaked at $501K in Q1 2021.
  • 86 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q2 2026.

Based on Boothbay Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.